FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Tài liệu tham khảo
Arbeit, 1994, Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice, J. Virol., 68, 4358, 10.1128/jvi.68.7.4358-4368.1994
Arbeit, 1996, Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice, Oncogene, 13, 1847
Barbera-Guillem, 1999, Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies, Neoplasia, 1, 453, 10.1038/sj.neo.7900054
Barbera-Guillem, 2000, B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion, Cancer Immunol. Immunother., 48, 541, 10.1007/PL00006672
Baumann, 2001, Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung, J. Immunol., 167, 1022, 10.4049/jimmunol.167.2.1022
Bergtold, 2006, FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis, J. Immunol., 177, 7287, 10.4049/jimmunol.177.10.7287
Brandtzaeg, 2006, The B-cell system in inflammatory bowel disease, Adv. Exp. Med. Biol., 579, 149, 10.1007/0-387-33778-4_10
Chen, 1993, Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus, Int. Immunol., 5, 647, 10.1093/intimm/5.6.647
Coussens, 1996, Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice, Am. J. Pathol., 149, 1899
Coussens, 1999, Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis, Genes Dev., 13, 1382, 10.1101/gad.13.11.1382
Coussens, 2000, MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis, Cell, 103, 481, 10.1016/S0092-8674(00)00139-2
Dalgleish, 2002, Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer, Adv. Cancer Res., 84, 231, 10.1016/S0065-230X(02)84008-8
Daniel, 2005, CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer, Cancer Res., 65, 2018, 10.1158/0008-5472.CAN-04-3444
De Palma, 2008, Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis, Cancer Cell, 14, 299, 10.1016/j.ccr.2008.09.004
de Visser, 2004, Early neoplastic progression is complement independent, Neoplasia, 6, 768, 10.1593/neo.04250
de Visser, 2005, De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent, Cancer Cell, 7, 411, 10.1016/j.ccr.2005.04.014
de Visser, 2006, Paradoxical roles of the immune system during cancer development, Nat. Rev. Cancer, 6, 24, 10.1038/nrc1782
DeNardo, 2009, CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, Cancer Cell, 16, 91, 10.1016/j.ccr.2009.06.018
Giraudo, 2004, An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis, J. Clin. Invest., 114, 623, 10.1172/JCI200422087
Gokbuget, 2006, Novel antibody-based therapy for acute lymphoblastic leukaemia, Best Pract. Res. Clin. Haematol., 19, 701, 10.1016/j.beha.2006.06.008
Gurcan, 2009, A review of the current use of rituximab in autoimmune diseases, Int. Immunopharmacol., 9, 10, 10.1016/j.intimp.2008.10.004
Hagemann, 2008, “Re-educating” tumor-associated macrophages by targeting NF-kappaB, J. Exp. Med., 205, 1261, 10.1084/jem.20080108
Junankar, 2006, Analysis of immune cell infiltrates during squamous carcinoma development, J. Investig. Dermatol. Symp. Proc., 11, 36, 10.1038/sj.jidsymp.5650024
Lu, 2008, Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer, J. Proteome Res., 7, 1388, 10.1021/pr700818f
Lyon, 1982, A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice, Genet. Res., 39, 315, 10.1017/S001667230002098X
Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205
Markiewski, 2008, Modulation of the antitumor immune response by complement, Nat. Immunol., 9, 1225, 10.1038/ni.1655
Nakayama, 2004, Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors, J. Clin. Invest., 114, 1317, 10.1172/JCI22089
Nimmerjahn, 2008, Fcgamma receptors as regulators of immune responses, Nat. Rev. Immunol., 8, 34, 10.1038/nri2206
Ostrand-Rosenberg, 2008, Immune surveillance: a balance between protumor and antitumor immunity, Curr. Opin. Genet. Dev., 18, 11, 10.1016/j.gde.2007.12.007
Pollard, 2008, Macrophages define the invasive microenvironment in breast cancer, J. Leukoc. Biol., 84, 623, 10.1189/jlb.1107762
Pucci, 2009, A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes (TEMs), blood “resident” monocytes and embryonic macrophages suggests common functions and developmental relationships, Blood, 114, 901, 10.1182/blood-2009-01-200931
Shah, 2005, Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells, Int. J. Cancer, 117, 574, 10.1002/ijc.21177
Siegel, 2000, Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein, J. Exp. Med., 191, 1945, 10.1084/jem.191.11.1945
Soucek, 2007, Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors, Nat. Med., 13, 1211, 10.1038/nm1649
Takai, 2005, Fc receptors and their role in immune regulation and autoimmunity, J. Clin. Immunol., 25, 1, 10.1007/s10875-005-0353-8
Takai, 1994, FcR gamma chain deletion results in pleiotrophic effector cell defects, Cell, 76, 519, 10.1016/0092-8674(94)90115-5
Tan, 2007, Humoral immunity, inflammation and cancer, Curr. Opin. Immunol., 19, 209, 10.1016/j.coi.2007.01.001
Theoharides, 2004, Mast cells: the Jekyll and Hyde of tumor growth, Trends Immunol., 25, 235, 10.1016/j.it.2004.02.013
Zapata, 2009, Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer, Blood, 113, 4595, 10.1182/blood-2008-07-165456